Compass Pathways Plc (CMPS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $1.28B
Last updated: Nov 17, 2026 at 4:42 PM ET
Compass Pathways Plc (CMPS) Statistics
Compass Pathways Plc (CMPS) has a market cap of $1.28B and an enterprise value of $883.82M. Its share count is up 70.52% from a year earlier. It holds $392.99M more cash than debt, 30.78% of its market cap.
Total Valuation
Enterprise value is 30.78% below the market cap, as cash exceeds debt.
| Market Cap | $1.28B |
|---|---|
| Enterprise Value | $883.82M |
| Latest price (Nov 17, 2026) | $7.98 |
Key Dates
The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 53.31% over 52 weeks and trades 31.62% below its 50-day average.
| Beta (1Y) | 1.90 |
|---|---|
| 52-Week Change | +53.31% |
| 1-Month Change | -28.17% |
| 3-Month Change | -43.04% |
| 6-Month Change | -20.75% |
| 5-Year Change | -72.58% |
| Total Return (1Y) | +53.31% |
| Total Return (3Y CAGR) | +9.91% |
| Total Return (5Y CAGR) | -23.93% |
| Return vs SPY (1Y) | +36.49% |
| Max Drawdown (1Y) | -48.58% |
| Max Drawdown (3Y) | -81.00% |
| Sharpe Ratio (1Y) | 0.44 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $11.67 |
| 200-Day Average | $10.50 |
| 52-Week Range | $4.88 to $15.87 |
| RSI (14 Days) | 32.3 |
| Average Volume (20 Days) | 3.65M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.50x current liabilities, and total debt is 0.36x shareholder equity.
| Current Ratio | 1.50x |
|---|---|
| Quick Ratio | 1.50x |
| Debt / Equity | 0.36x |
| Interest Coverage | -47.29x |
Returns and Efficiency
Return on invested capital is -135.08% and return on equity is -187.45% over the last 12 months.
| Return on Equity (ROE) | -187.45% |
|---|---|
| Return on Assets (ROA) | -51.30% |
| Return on Invested Capital (ROIC) | -135.08% |
| Return on Capital Employed (ROCE) | -136.74% |
| ROA (5Y Average) | -64.52% |
Scores
CMPS has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$197.66M |
| Pretax Income | -$269.82M |
| Net Income | -$266.30M |
| EBIT | -$264.23M |
| Reported EPS (TTM) | -$1.58 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 27.37% of the $519.10M in total assets.
| Cash and Equivalents | $443.98M |
|---|---|
| Total Debt | $50.99M |
| Net Cash | $392.99M |
| Working Capital | $161.69M |
| Shareholder Equity | $142.07M |
| Total Assets | $519.10M |
| Total Liabilities | $377.03M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $0 of capital spending, operating cash flow left -$176.80M of free cash flow.
| Operating Cash Flow | -$176.80M |
|---|---|
| Capital Expenditures | $0 |
| Free Cash Flow | -$176.80M |
| FCF Per Share | -$1.25 |
| Depreciation and Amortization | $6.00K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
CMPS does not pay a dividend. Its free cash flow yield is -13.63%.
| FCF Yield | -13.63% |
|---|---|
| Shareholder Yield | 0.00% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CMPS
What is CMPS's market cap?
Compass Pathways Plc has a market cap of $1.28B. Its enterprise value, which adds debt and subtracts cash, is $883.82M.
How many shares of CMPS are outstanding?
Compass Pathways Plc has 162.57M shares outstanding. The count is up 70.52% from a year earlier.
Does CMPS pay a dividend?
No. Compass Pathways Plc does not pay a dividend.
How much debt does CMPS have?
Compass Pathways Plc has $50.99M of total debt and $443.98M of cash and equivalents, a net cash position of $392.99M.
CMPS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors